Leeward Investments LLC MA lifted its holdings in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 17.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 97,176 shares of the semiconductor company's stock after purchasing an additional 14,304 shares during the quarter. Leeward Investments LLC MA owned approximately 0.30% of Silicon Laboratories worth $10,939,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Raymond James Financial Inc. acquired a new position in shares of Silicon Laboratories during the 4th quarter worth $14,252,000. Arizona State Retirement System increased its position in Silicon Laboratories by 1.8% during the fourth quarter. Arizona State Retirement System now owns 9,360 shares of the semiconductor company's stock worth $1,163,000 after buying an additional 167 shares during the last quarter. Oppenheimer Asset Management Inc. increased its position in Silicon Laboratories by 2.9% during the first quarter. Oppenheimer Asset Management Inc. now owns 7,379 shares of the semiconductor company's stock worth $831,000 after buying an additional 210 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Silicon Laboratories by 9.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,334 shares of the semiconductor company's stock valued at $290,000 after acquiring an additional 206 shares during the last quarter. Finally, Rhumbline Advisers increased its holdings in shares of Silicon Laboratories by 3.5% during the 1st quarter. Rhumbline Advisers now owns 104,407 shares of the semiconductor company's stock valued at $11,753,000 after acquiring an additional 3,550 shares during the last quarter.
Silicon Laboratories Price Performance
Shares of Silicon Laboratories stock traded up $0.85 during midday trading on Friday, hitting $153.55. The company had a trading volume of 261,814 shares, compared to its average volume of 345,396. The business's 50 day simple moving average is $129.53 and its two-hundred day simple moving average is $126.83. The stock has a market cap of $5.00 billion, a PE ratio of -30.05 and a beta of 1.47. Silicon Laboratories, Inc. has a 1-year low of $82.82 and a 1-year high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.01. Silicon Laboratories had a negative net margin of 25.16% and a negative return on equity of 8.80%. The company had revenue of $177.71 million for the quarter, compared to the consensus estimate of $177.48 million. During the same quarter in the previous year, the firm posted ($0.92) EPS. The business's revenue was up 67.0% compared to the same quarter last year. On average, sell-side analysts expect that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.
Insider Buying and Selling
In other news, CEO Robert Matthew Johnson sold 5,879 shares of Silicon Laboratories stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $131.20, for a total transaction of $771,324.80. Following the sale, the chief executive officer owned 73,688 shares of the company's stock, valued at approximately $9,667,865.60. This trade represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Christy Wyatt sold 546 shares of the business's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total value of $57,029.70. Following the sale, the director owned 8,492 shares in the company, valued at approximately $886,989.40. This represents a 6.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,626 shares of company stock valued at $1,509,319 over the last three months. 1.60% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
A number of brokerages have recently commented on SLAB. Susquehanna increased their price objective on Silicon Laboratories from $100.00 to $110.00 and gave the company a "neutral" rating in a report on Wednesday, May 14th. Stifel Nicolaus lowered their price target on Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating on the stock in a report on Thursday, April 17th. Barclays lowered their target price on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 22nd. Needham & Company LLC reiterated a "buy" rating and issued a $150.00 target price on shares of Silicon Laboratories in a research note on Wednesday, May 14th. Finally, Benchmark reiterated a "buy" rating and issued a $160.00 target price on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $126.50.
View Our Latest Research Report on SLAB
Silicon Laboratories Company Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Recommended Stories

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report